Company: IMRX
Filing Date: 2025-04-21
Form Type: DEF 14A
Source: 0001790340-25-000053
Chunk: 25

Company: Immuneering Corp
Filing Date: 2025-04-21
Form: DEF 14A
Chunk 25
---
 composition, the composition of its committees and the independence of our directors and considered whether any director has a material relationship with us that could compromise his or her ability to exercise independent judgment in carrying out his or her responsibilities. Based upon information requested from and provided by each director concerning his or her background, employment and affiliations, including family relationships, our Board of Directors has determined that none of Ann E. Berman, Robert J. Carpenter, Peter Feinberg, Diana F. Hausman, Laurie B. Keating and Thomas J. Schall, representing six of our seven directors, has a relationship that would interfere with the exercise of independent judgment in carrying out the responsibilities of a director and that each of these directors qualifies as “independent” as that term is defined under the Nasdaq rules. In making this determination, our Board of Directors considered the relationships that each non-employee director has with us and all other facts and circumstances our Board of Directors deemed relevant in determining their independence, including the director’s beneficial ownership of our common stock and the relationships of our non-employee directors with certain of our significant stockholders.

#### Board Committees
Our Board of Directors has established three standing committees: an audit committee, a compensation committee and a nominating and corporate governance committee, each of which has the composition and the responsibilities described below. In addition, from time to time, special committees may be established under the direction of our Board of Directors when necessary to address specific issues. Each of the audit committee, the compensation committee and the nominating and corporate governance committee operates pursuant to a written charter.

| Name                       |     | Audit     
 Committee |     | Nominating 
 and        
 Corporate  
 Governance 
 Committee  |     | Compensation 
 Committee    |
| Ann E. Berman              |     | Chair     |     | X          |     |              |
| Robert J. Carpenter        |     |           |     |            |     | X            |
| Peter Feinberg             |     | X         |     | X          |     |              |
| Diana F. Hausman, M.D.     |     |           |     | Chair      |     | X            |
| Laurie B. Keating          |     | X         |     |            |     | Chair        |
| Thomas J. Schall, Ph.D.    |     |           |     |            |     | X            |
| Benjamin J. Zeskind, Ph.D. |     |           |     |            |     |              |